ClinicalTrials.govpublic full text
Brodalumab in the Treatment of Immune-Related Adverse Events
breast cancer, esophageal cancer, kidney cancer, lung cancer, thyroid cancer, gynecologic cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 346915
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.